Financial Architects (New Jersey)’s Immunogen Inc IMGN Stock Holding History

Financial Architects (New Jersey)’s Portfolio IMGN Stock Details IMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-1,100	Closed	-$3K	–	1518
2019 Q1	$3K	Hold	1,100	–	–	﹤0.01%	1304
2018 Q4	$5K	Hold	1,100	–	–	﹤0.01%	1151
2018 Q3	$10K	Hold	1,100	–	–	﹤0.01%	1127
2018 Q2	$11K	Sell	1,100 -96	-8%	-$1.01K	﹤0.01%	972
2018 Q1	$13K	Hold	1,196	–	–	﹤0.01%	1011
2017 Q4	$8K	Hold	1,196	–	–	﹤0.01%	1213
2017 Q3	$9K	Hold	1,196	–	–	﹤0.01%	1165
2017 Q2	$9K	Hold	1,196	–	–	﹤0.01%	1175
2017 Q1	$5K	Hold	1,196	–	–	﹤0.01%	1299
2016 Q4	$2K	Buy	1,196 +100	+9%	+$201	﹤0.01%	1312
2016 Q3	$3K	Hold	1,096	–	–	﹤0.01%	1284
2016 Q2	$3K	Buy	+1,096	New	+$6.87K	﹤0.01%	1248
2014 Q4	–	Sell	-83	Closed	-$1K	–	1056
2014 Q3	$1K	Buy	+83	New	+$939	﹤0.01%	866

Other funds holding IMGN

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Financial Architects (New Jersey)'s IMGN Position: Q2 2019 in Review

Financial Architects (New Jersey) sold out of Immunogen Inc (IMGN) in Q2 2019, closing a stake of 1,100 shares — an estimated $3K sold.

Financial Architects (New Jersey) first reported a position in IMGN in Q3 2014 and held it in 13 quarters. The position peaked at $13K in Q1 2018. 192 funds tracked by Wall St. Rank hold IMGN as of Q2 2019.

Financial Architects (New Jersey) reported no remaining Immunogen Inc position as of Q2 2019 after selling out during the quarter.
Financial Architects (New Jersey) sold 1,100 Immunogen Inc shares in Q2 2019, an estimated $3K.
Financial Architects (New Jersey) first reported a position in Immunogen Inc in Q3 2014 and held it in 13 quarters.
Financial Architects (New Jersey)'s Immunogen Inc position peaked at $13K in Q1 2018.
192 funds tracked by Wall St. Rank held Immunogen Inc as of Q2 2019.

Based on Financial Architects (New Jersey)'s 13F filing for Q2 2019, filed 14 Aug 2019.